PEAK6 Investments’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,750
Closed -$1.63M 3517
2024
Q2
$1.43M Buy
17,750
+11,415
+180% +$1.04M ﹤0.01% 1581
2024
Q1
$584K Sell
6,335
-67,599
-91% -$6.48M ﹤0.01% 2331
2023
Q4
$7.8M Buy
73,934
+31,556
+74% +$3.18M 0.03% 589
2023
Q3
$4.6M Buy
+42,378
New +$4.69M 0.02% 760
2023
Q1
Sell
-67,273
Closed -$9.24M 4289
2022
Q4
$10.1M Buy
67,273
+31,467
+88% +$4.84M 0.06% 371
2022
Q3
$4.83M Buy
35,806
+32,057
+855% +$4.9M 0.02% 858
2022
Q2
$559K Sell
3,749
-81,658
-96% -$12.5M ﹤0.01% 3703
2022
Q1
$14.6M Sell
85,407
-1,972
-2% -$331K 0.03% 541
2021
Q4
$22.5M Sell
87,379
-124,851
-59% -$34.2M 0.05% 381
2021
Q3
$57.9M Buy
212,230
+197,349
+1,326% +$62.7M 0.13% 128
2021
Q2
$3.33M Buy
14,881
+8,412
+130% +$1.59M 0.01% 1426
2021
Q1
$706K Buy
+6,469
New +$687K ﹤0.01% 2889

Other funds holding BNTX

PEAK6 Investments's BNTX Position: Q3 2024 in Review

PEAK6 Investments sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 17,750 shares — an estimated $1.63M sold.

PEAK6 Investments first reported a position in BNTX in Q1 2021 and held it in 12 quarters. The position peaked at $57.9M in Q3 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • PEAK6 Investments reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 17,750 BioNTech shares in Q3 2024, an estimated $1.63M.
  • PEAK6 Investments first reported a position in BioNTech in Q1 2021 and held it in 12 quarters.
  • PEAK6 Investments's BioNTech position peaked at $57.9M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.